CRIS Current Research Information System

BRIGHI, NICOLE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.652
AS - Asia 2.289
EU - Europa 1.886
AF - Africa 155
SA - Sud America 121
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.107
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.620
SG - Singapore 894
CN - Cina 498
VN - Vietnam 434
DE - Germania 390
IT - Italia 381
GB - Regno Unito 291
SE - Svezia 260
HK - Hong Kong 202
IN - India 114
IE - Irlanda 104
BR - Brasile 84
NL - Olanda 82
RU - Federazione Russa 78
FR - Francia 69
KR - Corea 57
CH - Svizzera 51
TG - Togo 42
CI - Costa d'Avorio 36
SC - Seychelles 36
FI - Finlandia 33
BG - Bulgaria 31
BE - Belgio 30
JO - Giordania 28
ZA - Sudafrica 23
CA - Canada 20
ID - Indonesia 17
EE - Estonia 16
UA - Ucraina 16
AR - Argentina 14
JP - Giappone 14
AT - Austria 12
PL - Polonia 12
NG - Nigeria 10
TR - Turchia 7
CO - Colombia 6
LT - Lituania 6
CL - Cile 5
EC - Ecuador 5
GR - Grecia 5
MX - Messico 5
NI - Nicaragua 5
ES - Italia 4
PY - Paraguay 4
TH - Thailandia 4
BD - Bangladesh 3
IQ - Iraq 3
MA - Marocco 3
RO - Romania 3
AU - Australia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
IR - Iran 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DK - Danimarca 1
EG - Egitto 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
MG - Madagascar 1
NO - Norvegia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.107
Salva come PNG Salva come JPEG
Città #
Singapore 650
Ashburn 375
Fairfield 257
Chandler 252
Southend 250
Hong Kong 201
Santa Clara 127
Hefei 118
Woodbridge 118
Seattle 115
Houston 114
Wilmington 112
Ho Chi Minh City 107
Princeton 106
Dublin 99
Beijing 86
Cambridge 84
Hanoi 75
Boardman 64
Ann Arbor 62
Seoul 56
Bern 47
Bologna 44
Lomé 42
Krefeld 41
Abidjan 36
Berlin 35
Los Angeles 35
Rome 35
Dallas 31
New York 31
Sofia 31
Dong Ket 30
Milan 30
Redondo Beach 30
Amman 28
Frankfurt am Main 28
Westminster 28
Helsinki 25
Turin 23
Des Moines 21
San Diego 21
Brussels 20
Buffalo 17
Bad Bellingen 15
Munich 15
Changsha 14
Da Nang 14
Jakarta 14
Nanjing 13
Tokyo 13
Florence 11
Quận Bình Thạnh 11
São Paulo 11
Bengaluru 10
Haiphong 10
Nuremberg 10
Padova 10
Shenyang 10
Abeokuta 9
Falkenstein 9
Phoenix 9
Bühl 8
Chicago 8
Hangzhou 8
Jinan 8
London 8
Ravenna 8
Toronto 8
Chengdu 7
Guangzhou 7
Ha Long 7
Hải Dương 7
Ninh Bình 7
Shanghai 7
The Dalles 7
Wuhan 7
Amsterdam 6
Bremen 6
Bắc Giang 6
Montescudo 6
Montreal 6
Nanchang 6
Naples 6
Redmond 6
Roubaix 6
Saint Petersburg 6
San Francisco 6
Tianjin 6
Torino 6
Brooklyn 5
Düsseldorf 5
Lappeenranta 5
Managua 5
Norwalk 5
Orem 5
Redwood City 5
Salt Lake City 5
Tongling 5
Vienna 5
Totale 4.585
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 401
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 365
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 249
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 200
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 192
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 182
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 161
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 160
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives 159
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 151
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 150
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 145
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 143
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 142
Severe hypernatremia as a predictor of mortality after percutaneous endoscopic gastrostomy (PEG) placement 137
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 134
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 130
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study 128
Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study 128
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 127
Cancer in the elderly: is it time for palliative care in geriatric oncology? 125
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis 125
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 124
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor 121
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations 121
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition of splenic lesions: systematic review with pooled analysis 118
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 117
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging 112
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 111
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 109
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 107
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 105
Chromogranin A usefulness in small non-functioning pancreatic neuroendocrine tumors surgical management 104
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes 102
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 102
Safety and efficacy of endoscopic ultrasound‐guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta‐analysis 100
Palliative care training and research: the development in europe and the bologna experience. 100
Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience 97
The functioning side of the pancreas: a review on insulinomas 96
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 96
Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis 92
Plasma androgen receptor in prostate cancer 91
Cross-cultural differences in hospices. A retrospective study in Italy 85
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes 85
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 84
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 83
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience 82
Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study From the French Group of Endocrine Tumors (GTE) 80
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study 80
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer 79
Routine EUS-guided tissue acquisition in patients with resectable solid pancreatic masses - Pros and cons reassessment in 2020 77
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 77
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 74
New prognostic biomarkers in metastatic castration-resistant prostate cancer 70
Knife-assisted resection (KAR) for small rectal neuroendocrine neoplasia 69
Cutaneous Scapular Lesion in an Elderly Woman 67
An update on our ability to monitor castration-resistant prostate cancer dynamics with cell-free DNA 67
Quality of life in patients with long-standing chronic non-pathological pancreatic hyperenzymemia 66
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 63
Response 54
Totale 7.301
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.884
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021296 0 0 0 0 0 15 14 23 68 32 13 131
2021/2022917 41 14 35 53 83 37 50 49 53 96 275 131
2022/20231.132 85 152 52 140 89 102 35 65 224 30 67 91
2023/2024490 26 56 28 28 20 67 9 26 167 16 21 26
2024/20251.493 93 191 131 101 228 96 79 64 20 121 68 301
2025/20261.814 488 286 244 243 412 141 0 0 0 0 0 0
Totale 7.301